Prediction of Duration of Mechanical Ventilation in ARDS (PIONEER)

March 19, 2024 updated by: Jesus Villar, Dr. Negrin University Hospital

Predicting Length of Mechanical Ventilation in Moderate-to-severe Acute Respiratory Distress Syndrome Using Machine Learning

The investigators are planning to perform a secondary analysis of an academic dataset of 1,303 patients with moderate-to-severe acute respiratory distress syndrome (ARDS) included in several published cohorts (NCT00736892, NCT022288949, NCT02836444, NCT03145974), aimed to characterize the best early scenario during the first three days of diagnosis to predict duration of mechanical ventilation in the intensive care unit (ICU) using supervised machine learning (ML) approaches.

Study Overview

Detailed Description

The acute respiratory distress syndrome (ARDS) is an important cause of morbidity, mortality, and costs in intensive care units (ICUs) worldwide. Most ARDS patients require mechanical ventilation (MV). Few studies have investigated the prediction of MV duration of ARDS.

For model description and testing, the investigators will extract data from he first three ICU days after diagnosis of moderate-to-severe ARDS from patients included in the de-identified database, which includes 1,000 mechanically ventilated patients enrolled in several observational cohorts in Spain, coordinated by the principal investigator (JV), and funded by the Instituto de Salud Carlos III (ISCIII). The investigators will follow the TRIPOD guidelines and machine learning techniques will be implemented [Random Forest (RF), eXtreme Gradient Boosting (XGBoost), and Logistic regression analysis) for the development and accuracy of prediction models. Disease progression will be tracked along those 3 ICU days to assess lung severity according to Berlin criteria. For external validation, the investigators will use 303 patients enrolled in a contemporary observational study (NCT03145974). The investigators will evaluate the accuracy of prediction models by calculation several statistics, such as sensitivity, specificity, positive predictive value, negative value for each model. The investigators will select the best early prediction model with data captured on the 1st, 2nd, or 3rd day.

Study Type

Observational

Enrollment (Actual)

1303

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Albacete, Spain
        • Complejo Hospitalario de Albacete
      • Albacete, Spain, 02006
        • Complejo Hospitalario Universitario de Albacete (ICU)
      • Barcelona, Spain, 08036
        • Department of Anesthesia, Hospital Clinic
      • Ciudad Real, Spain, 13005
        • Hospital General de Ciudad Real (ICU)
      • Cuenca, Spain
        • Hospital Virgen De La Luz
      • La Coruña, Spain, 15006
        • Hospital Universitario de A Coruña (ICU)
      • León, Spain
        • Complejo Hospitalario Universitario de León
      • Madrid, Spain
        • Hospital Fundación Jiménez Díaz
      • Madrid, Spain, 28046
        • Hospital Universitario La Paz (ICU)
      • Madrid, Spain, 28034
        • Hospital Universitario Ramón y Cajal (Anesthesia)
      • Murcia, Spain, 30120
        • Hospital Universitario Virgen de Arrixaca (ICU)
      • Málaga, Spain
        • Hospital Universitario Carlos Haya
      • Málaga, Spain, 29010
        • Hospital Universitario Regional de Malaga Carlos Haya (ICU)
      • Valladolid, Spain, 47012
        • Hospital Universitario Río Hortega (ICU)
      • Zamora, Spain, 49022
        • Hospital Virgen de la Concha (ICU)
    • Las Palmas
      • Las Palmas De Gran Canaria, Las Palmas, Spain, 35019
        • Hospital Universitario Dr. Negrin
    • Madrid
      • Majadahonda, Madrid, Spain, 28222
        • Hospital Universitario Puerta de Hierro (ICU)
    • Tenerife
      • Santa Cruz de Tenerife, Tenerife, Spain
        • Hospital Universitario NS de Candelaria
    • Toledo
      • Talavera de la Reina, Toledo, Spain
        • Hospital NS del Prado
      • Cardiff, United Kingdom
        • Cardiff University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

N/A

Sampling Method

Non-Probability Sample

Study Population

De-identified dataset including 1,303 patients with moderate/severe ARDS admitted consecutively in a network of Spanish ICUs.

Description

Inclusion Criteria:

  • Berlin criteria for moderate to severe acute respiratory distress syndrome

Exclusion Criteria:

  • Postoperative patients ventilated <24h
  • brain death patients

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Confirmatory cohort
It will contain 303 patients (for external validation)
we will use robust machine learning approaches, such as Random Forest and XGBoost.
Derivation and testing cohort
It will contain 1000 ARDS patients
we will use robust machine learning approaches, such as Random Forest and XGBoost.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Days on mechanical ventilation
Time Frame: from diagnosis to extubation
Duration of mechanical ventilation
from diagnosis to extubation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
ICU mortality
Time Frame: up to 24 weeks
mortality in the intensive care unit
up to 24 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jesús Villar, Hospital Universitario D. Negrin

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 14, 2023

Primary Completion (Actual)

February 2, 2024

Study Completion (Actual)

February 2, 2024

Study Registration Dates

First Submitted

August 4, 2023

First Submitted That Met QC Criteria

August 14, 2023

First Posted (Actual)

August 15, 2023

Study Record Updates

Last Update Posted (Actual)

March 20, 2024

Last Update Submitted That Met QC Criteria

March 19, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acute Respiratory Distress Syndrome

Clinical Trials on Logistic regression Cross validation Area under the RIC curves Machine learning analysis. .

3
Subscribe